| scholarly article | Q13442814 |
| P50 | author | Manoja K Brahma | Q64682485 |
| Graham R. McGinnis | Q41500050 | ||
| P2093 | author name string | Adam R Wende | |
| Martin E Young | |||
| P2860 | cites work | Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production | Q84405012 |
| Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure | Q44082558 | ||
| Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice | Q44179204 | ||
| Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy | Q44182277 | ||
| Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice | Q44534251 | ||
| Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases | Q44781340 | ||
| Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia | Q44801333 | ||
| Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload | Q44927100 | ||
| Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy | Q45200908 | ||
| Hypercatabolic syndrome: molecular basis and effects of nutritional supplements with amino acids | Q46565780 | ||
| Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy | Q46648922 | ||
| Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization | Q46735147 | ||
| Exhaled acetone as a new biomaker of heart failure severity | Q48653946 | ||
| Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice | Q50688253 | ||
| Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart | Q50782443 | ||
| Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure | Q51025352 | ||
| Exhaled Acetone Concentration Is Related to Hemodynamic Severity in Patients With Non-Ischemic Chronic Heart Failure | Q51536590 | ||
| Metabolic Staging in Human Heart Failure: Circulating Acylcarnitines and the Failing Heart's Energetic Signature | Q51551304 | ||
| Impaired energy metabolism of the taurine‑deficient heart | Q51582758 | ||
| Low carbohydrate ketogenic diet enhances cardiac tolerance to global ischaemia | Q53529577 | ||
| Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice | Q54609364 | ||
| A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation | Q55043340 | ||
| Effect of taurine supplementation on exercise capacity of patients with heart failure. | Q55053971 | ||
| Branched-chain amino acids ameliorate heart failure with cardiac cachexia in rats. | Q55053981 | ||
| Role of protein phosphorylation in excitation-contraction coupling in taurine deficient hearts. | Q55069898 | ||
| Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction | Q57396503 | ||
| Pathophysiology of chronic heart failure | Q67518120 | ||
| Usefulness of taurine in chronic congestive heart failure and its prospective application | Q68061936 | ||
| Effects of moderate hypertension on cardiac function and metabolism in the rabbit | Q68347187 | ||
| Increased glycolytic metabolism in cardiac hypertrophy and congestive failure | Q68447663 | ||
| Breath acetone in congestive heart failure | Q71551032 | ||
| Fatty acid oxidation enzyme gene expression is downregulated in the failing heart | Q71828329 | ||
| Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts | Q72144367 | ||
| Altered coenzyme A and carnitine metabolism in pressure-overload hypertrophied hearts | Q72786969 | ||
| Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms | Q73035986 | ||
| Heart failure ketosis | Q73830470 | ||
| Apoptotic versus autophagic cell death in heart failure | Q74257419 | ||
| Regulation of Energy Metabolism of the Heart during Acute Increase in Heart Work | Q77477972 | ||
| Glucose for the heart | Q77932890 | ||
| Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart | Q79224445 | ||
| Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension | Q79294443 | ||
| Storage and oxidation of long-chain fatty acids in the C57/BL6 mouse heart as measured by NMR spectroscopy | Q79871363 | ||
| Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy | Q80979295 | ||
| High-fat diet prevents cardiac hypertrophy and improves contractile function in the hypertensive dahl salt-sensitive rat | Q81239486 | ||
| Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure | Q81365268 | ||
| Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure | Q82736120 | ||
| Mitochondrion as a Target for Heart Failure Therapy- Role of Protein Lysine Acetylation | Q26801419 | ||
| Pyridine Nucleotide Regulation of Cardiac Intermediary Metabolism | Q26822692 | ||
| Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis | Q26853332 | ||
| Glucose Transporters in Cardiac Metabolism and Hypertrophy | Q28075863 | ||
| Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies | Q28273319 | ||
| Regulation of signal transduction by reactive oxygen species in the cardiovascular system | Q28391569 | ||
| The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress | Q28506886 | ||
| Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41) | Q28512084 | ||
| Insulin Signaling and Heart Failure. | Q30377910 | ||
| Post-translational modifications of the cardiac proteome in diabetes and heart failure | Q33361067 | ||
| GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure. | Q33680469 | ||
| High-fat, low-carbohydrate diet promotes arrhythmic death and increases myocardial ischemia-reperfusion injury in rats. | Q34062837 | ||
| Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. | Q34117304 | ||
| PPAR signaling in the control of cardiac energy metabolism | Q34204732 | ||
| Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor | Q34316485 | ||
| Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease | Q34317717 | ||
| Allopurinol Acutely Increases Adenosine Triphospate Energy Delivery in Failing Human Hearts | Q34398552 | ||
| Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling. | Q34404106 | ||
| Wasting as independent risk factor for mortality in chronic heart failure | Q34421966 | ||
| Cardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia. | Q34431401 | ||
| Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans | Q34557869 | ||
| Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach | Q34559786 | ||
| Protein O-GlcNAcylation and cardiovascular (patho)physiology | Q34683061 | ||
| Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy | Q34742779 | ||
| G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. | Q35041039 | ||
| Plasma amino acid profiling identifies specific amino acid associations with cardiovascular function in patients with systolic heart failure | Q35058430 | ||
| Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course | Q35370515 | ||
| Altered systemic ketone body metabolism in advanced heart failure | Q35594825 | ||
| Metabolomic fingerprint of heart failure with preserved ejection fraction | Q35641415 | ||
| Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice | Q35677381 | ||
| Cardiac autophagy is a maladaptive response to hemodynamic stress | Q35839989 | ||
| Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies | Q35902401 | ||
| Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. | Q35974413 | ||
| Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review | Q35980293 | ||
| A novel mouse model of lipotoxic cardiomyopathy | Q36016938 | ||
| Normalizing the metabolic phenotype after myocardial infarction: impact of subchronic high fat feeding | Q36024334 | ||
| Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis | Q36026001 | ||
| Removal of Abnormal Myofilament O-GlcNAcylation Restores Ca2+ Sensitivity in Diabetic Cardiac Muscle. | Q36104643 | ||
| Insulin resistance improves metabolic and contractile efficiency in stressed rat heart | Q36117453 | ||
| GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle | Q36156657 | ||
| Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy | Q36211992 | ||
| Peroxisome Proliferator Activated Receptor-α Association With Silent Information Regulator 1 Suppresses Cardiac Fatty Acid Metabolism in the Failing Heart | Q36296771 | ||
| Feeding the fibrillating heart: Dichloroacetate improves cardiac contractile dysfunction following VF. | Q36339422 | ||
| Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity | Q36359620 | ||
| Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes | Q36385967 | ||
| The Failing Heart Relies on Ketone Bodies as a Fuel | Q36614537 | ||
| Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure. | Q36654675 | ||
| Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload-Induced Mitochondrial Dysfunction and Heart Failure. | Q36739432 | ||
| Ketone body metabolism and cardiovascular disease | Q36764435 | ||
| The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis | Q36807931 | ||
| Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification. | Q36869450 | ||
| Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure | Q36932534 | ||
| Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation | Q37032295 | ||
| A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload | Q37038725 | ||
| Low carbohydrate diet decreases myocardial insulin signaling and increases susceptibility to myocardial ischemia | Q37097785 | ||
| Control of lipolysis by natriuretic peptides and cyclic GMP. | Q37109051 | ||
| Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation | Q37193340 | ||
| Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation | Q37241211 | ||
| Glucose transporter-8 (GLUT8) mediates glucose intolerance and dyslipidemia in high-fructose diet-fed male mice | Q37249085 | ||
| Inducible overexpression of GLUT1 prevents mitochondrial dysfunction and attenuates structural remodeling in pressure overload but does not prevent left ventricular dysfunction. | Q37328748 | ||
| SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states | Q37341063 | ||
| Loss of the eukaryotic initiation factor 2α kinase general control nonderepressible 2 protects mice from pressure overload-induced congestive heart failure without affecting ventricular hypertrophy. | Q37365394 | ||
| Impaired assembly and post-translational regulation of 26S proteasome in human end-stage heart failure | Q37396042 | ||
| Markers of autophagy are downregulated in failing human heart after mechanical unloading | Q37423543 | ||
| Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance | Q37575903 | ||
| O-GlcNAc and the cardiovascular system. | Q37619691 | ||
| The adrenergic-fatty acid load in heart failure | Q37619839 | ||
| Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart | Q37629277 | ||
| Myocardial fatty acid metabolism in health and disease | Q37677921 | ||
| Atrial natriuretic peptides in heart failure: pathophysiological significance, diagnostic and prognostic value | Q37909469 | ||
| Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis | Q37989678 | ||
| Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart | Q38086415 | ||
| Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction. | Q38163601 | ||
| Amino acids and derivatives, a new treatment of chronic heart failure? | Q38219915 | ||
| Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. | Q38237575 | ||
| Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure | Q38347423 | ||
| Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models | Q38375945 | ||
| Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets | Q38390699 | ||
| Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure | Q38652938 | ||
| Impact of empagliflozin in patients with diabetes and heart failure | Q38822815 | ||
| Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications. | Q38912082 | ||
| Presentation blood glucose and death, hospitalization, and future diabetes risk in patients with acute heart failure syndromes. | Q39062440 | ||
| Molecular profiling of dilated cardiomyopathy that progresses to heart failure | Q39726366 | ||
| Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure | Q40086861 | ||
| Regulation of fatty acid oxidation in the mammalian heart in health and disease | Q40682538 | ||
| Elevated serum glucose levels and survival after acute heart failure: a population-based perspective | Q41668688 | ||
| Carnitine — from cellular mechanisms to potential clinical applications in heart disease | Q41702188 | ||
| Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes. | Q41767266 | ||
| Insulin receptor substrate signaling suppresses neonatal autophagy in the heart. | Q42818693 | ||
| Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling. | Q42863016 | ||
| Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure | Q42928039 | ||
| Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure | Q43153623 | ||
| Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload | Q43207763 | ||
| Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis | Q43645320 | ||
| Metabolic Gene Expression in Fetal and Failing Human Heart | Q43819742 | ||
| Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet | Q43868499 | ||
| Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. | Q44054769 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 297-310 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | JACC. Basic to Translational Science | Q27727237 |
| P1476 | title | Metabolic Origins of Heart Failure | |
| P478 | volume | 2 |
| Q98613654 | CD36 (SR-B2) as a Target to Treat Lipid Overload-Induced Cardiac Dysfunction |
| Q57072502 | Changing Metabolism in Differentiating Cardiac Progenitor Cells-Can Stem Cells Become Metabolically Flexible Cardiomyocytes? |
| Q91971340 | Defining decreased protein succinylation of failing human cardiac myofibrils in ischemic cardiomyopathy |
| Q91994884 | Depressed Myocardial Energetic Efficiency Increases Risk of Incident Heart Failure: The Strong Heart Study |
| Q52631083 | Dietary Fat is a Key Determinant in Balancing Mitochondrial Dynamics in Heart Failure: A Novel Mechanism Underlying the Obesity Paradox |
| Q91908510 | Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes |
| Q64891344 | Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure. |
| Q92662725 | Glucose Metabolism in Cardiac Hypertrophy and Heart Failure |
| Q64911489 | Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction. |
| Q91658108 | Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance |
| Q55017834 | Integration of Metabonomics and Transcriptomics Reveals the Therapeutic Effects and Mechanisms of Baoyuan Decoction for Myocardial Ischemia. |
| Q91943626 | Metabolic Coupling as a Therapeutic Strategy for Heart Failure |
| Q88779937 | Metabolic remodeling of substrate utilization during heart failure progression |
| Q93347609 | Metformin intervention prevents cardiac dysfunction in a murine model of adult congenital heart disease |
| Q101237654 | Mitochondrial pyruvate carriers are required for myocardial stress adaptation |
| Q91637200 | Pathological Mechanistic Studies of Osimertinib Resistance in Non-Small-Cell Lung Cancer Cells Using an Integrative Metabolomics-Proteomics Analysis |
| Q89712807 | Pseudouridine and N-formylmethionine associate with left ventricular mass index: Metabolome-wide association analysis of cardiac remodeling |
| Q91860801 | Rapamycin persistently improves cardiac function in aged, male and female mice, even following cessation of treatment |
| Q60937837 | Semantic Multi-Classifier Systems Identify Predictive Processes in Heart Failure Models across Species |
| Q64077110 | Serum Concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are Associated with Increased 3-Month Mortality in Acute Heart Failure Patients |
| Q98499656 | The role of ectopic adipose tissue: benefit or deleterious overflow? |
| Q60950054 | and Are Affected by Stretch in HL-1 Atrial Myocytes |
Search more.